SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Vimta Labs Ltd

BSE: 524394 NSE: VIMTALABS ISIN: INE579C01029
  |   Sector:  Miscellaneous   |   Industry:  Business Support

Snapshot

Q.1 Which industry/sub-sector does Vimta Labs Ltd belong to?
Vimta Labs Ltd belongs to the Miscellaneous sector, operating specifically within the Business Support segment.
Q.2 Is Vimta Labs Ltd a good quality company?
Vimta Labs Ltd is a quality company, based on a 10 year financial track record .
Q.3 Is Vimta Labs Ltd undervalued or overvalued?
Vimta Labs Ltd appears Overvalued , as its key valuation ratios are above with their past averages.
Q.4 Is Vimta Labs Ltd a good buy now?
Vimta Labs Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways . However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Vimta Labs Ltd?
Vimta Labs Ltd revenue growth is 19.2% for FY-2025. , which is above its 5 year CAGR of 13.7% , indicating faster growth.
Q.2 Gross Profit margin of Vimta Labs Ltd?
Vimta Labs Ltd Gross profit margin which is the profit after deduction of direct costs, is 36.1% for FY-2025 , which is above its 5 year median of 28.9% , indicating increasing margins.
Q.3 Operating Profit Margin of Vimta Labs Ltd?
Vimta Labs Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 35.45% for FY-2025 , which is above its 5 year median of 28.97% indicating increasing margins.
Q.4 Net Profit Margin of Vimta Labs Ltd?
Vimta Labs Ltd Net Profit Margin is 19.41% for FY-2025 , is above with its 5 year median of 14.88%, indicating increasing margins.
Q.5 Return on Asset of Vimta Labs Ltd?
Vimta Labs Ltd Return on Asset is 15.76(x), which is above its 5 year historical median of 14.25(x), indicating improved asset utilization efficiency.
Q.6 Return on Equity (ROE) of Vimta Labs Ltd?
Vimta Labs Ltd Return on equity is 19.65% for FY-2025 , which is above its historical median of 19.32%, indicating the business is making better use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Vimta Labs Ltd?
Vimta Labs Ltd Return on capital employed is 25.23% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 14%, indicating value creation .
Q.8 Cash conversion cycle of Vimta Labs Ltd?
Vimta Labs Ltd Cash conversion cycle is 114 , above its historical median of 95 , indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Q.9 Debt to Equity ratio of Vimta Labs Ltd?
Vimta Labs Ltd Debt-to-Equity ratio is 0.02 , which is above with the industry average of 0 , indicating higher debt levels in the industry.
Q.10 Debt to cash flow from operations of Vimta Labs Ltd?
Vimta Labs Ltd Debt to cash flow from operations is 0.09 , which is at a healthy level, indicating the business is able to service its debt comfortably.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Vimta Labs Ltd?
Promoters hold 35.90% of the Vimta Labs Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Vimta Labs Ltd vs industry peers?
Vimta Labs Ltd revenue CAGR is 13.74% , compared to the industry median CAGR of 7.1% , indicating faster growth and gaining its market share.

Valuation & price assessment

Q.1 Stock return of Vimta Labs Ltd over the last decade?
Over the last 9 years, the stock has delivered a CAGR of 28.3% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 28.3% 35.6% 37.6% 1.4%
Q.3 Valuation ratios of Vimta Labs Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 27.7 0.00 29.41
Price to Book 4.77 1.37 2.54
Price to Sales 5.27 1.38 4.88
EV to EBITDA 14.13 8.82 11.31

Check more companies

1. Prime Focus
2. Sagility
3. Syngene Internation.
4. International Gemolo
5. Indegene
6. NESCO
7. Latent View Analytic
8. Just Dial
9. CMS Info Systems
10. Sun Pharma Adv. Res
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×